Norleucine

Norleucine

SCHEMBL8710592

CCCC[C@H](N)C(=O)O.COC(=O)[C@@H](N)CCSC

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 2/20 0.44
SLC1A1 P43005 2/20 0.44
SLC1A3 P43003 1/20 0.44
NOD1 Q9Y239 4/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
DDAH1 O94760 1/20 0.41
NOS3 P29474 2/20 0.40
NOS1 P29475 2/20 0.40
CYP2C19 P33261 1/20 0.40
THPO P40225 1/20 0.40
NOS2 P35228 1/20 0.40
GRIK1 P39086 1/20 0.40
GRIK2 Q13002 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
BHMT Q93088 1/20 0.40
BHMT2 Q9H2M3 1/20 0.40
SLC15A1 P46059 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Norleucine SCHEMBL4068644 0.89 SLC1A2 (0.53) SLC1A2SLC1A1SLC1A3DDAH1NOS3
Norleucine SCHEMBL4068645 0.89 SLC1A2 (0.53) SLC1A2SLC1A1SLC1A3DDAH1NOS3
Norleucine SCHEMBL12485005 0.86 SLC1A2 (0.50) SLC1A2SLC1A1SLC1A3DDAH1NOS3
Norleucine SCHEMBL12485007 0.86 SLC1A2 (0.50) SLC1A2SLC1A1SLC1A3DDAH1NOS3
SCHEMBL108559 0.84 MARS1 (0.44)
SCHEMBL108560 0.84 MARS1 (0.44)
SCHEMBL3089957 0.84 MARS1 (0.44)
Ornithine SCHEMBL15322979 0.83 GSR (0.45) SLC1A2SLC1A1SLC1A3NOD1DDAH1
SCHEMBL4068647 0.83 DPP7 (0.41) SLC1A2SLC1A1SLC1A3NOD1CA1
Leucine SCHEMBL15323405 0.82 SLC7A5 (0.53) SLC1A2SLC1A1SLC1A3NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5786322-A DIAGNOSTIC DETERMINING A SITE OF INFLAMMATION IN PATIENT AFFYMAX TECHNOLOGIES N.V. (GB) 1998-07-28 US disclosed
US-5643873-A ANTIINFLAMMATORY AFFYMAX TECHNOLOGIES N.V. (AN) 1997-07-01 US disclosed